RENBP and prostate cancer: One hundred sixty-one statistically significant pathways (p < 0.05) were identified, with the Top 3 pathways being the AGE-RAGE signaling pathway in diabetic complications (hsa04933), lipid and atherosclerosis (hsa05417), and prostate cancer (hsa05215).